Charles Carroll Financial Partners, LLC Amgen Inc Transaction History

Charles Carroll Financial Partners, LLC

  • $92.9 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$229.03 - $291.01 $11,451 - $14,550
50 Added 0.4%
12,615 $3.31 Million
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $476,977 - $537,943
2,125 Added 20.35%
12,565 $2.83 Million
Q2 2022

Jul 27, 2022
BUY
$230.71 - $256.74 $926,300 - $1.03 Million
4,015 Added 62.49%
10,440 $2.54 Million
Q1 2022

May 12, 2022
BUY
$219.27 - $242.57 $1.41 Million - $1.56 Million
6,425 New
6,425 $1.55 Million

Others Institutions Holding AMGN

# of Institutions
3,075
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Charles Carroll Financial Partners, LLC Portfolio

Follow Charles Carroll Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Carroll Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Charles Carroll Financial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email